共 126 条
[1]
Reich DS(2018)Multiple sclerosis N Engl J Med. 378 169-80
[2]
Lucchinetti CF(2019)Multiple sclerosis—a review Eur J Neurol. 26 27-40
[3]
Calabresi PA(2014)Defining the clinical course of multiple sclerosis: the 2013 revisions Neurology 83 278-86
[4]
Dobson R(2015)Medication adherence measures: an overview Biomed Res Int. 2015 217047-98
[5]
Giovannoni G(2014)The impact of medication adherence on health outcomes for chronic metabolic diseases: a retrospective cohort study Res Social Adm Pharm 10 e87-44
[6]
Lublin FD(2014)Adherence and health care costs Risk Manag Healthc Policy 7 35-12
[7]
Reingold SC(2013)Treatment patterns in disease-modifying therapy for patients with multiple sclerosis in the United States Clin Ther 35 1501-20
[8]
Cohen JA(2010)Objective adherence monitoring in multiple sclerosis: initial validation and association with self-report Mult Scler 16 112-57
[9]
Lam WY(2014)The STAR Study: a real-world, international, observational study of the safety and tolerability of, and adherence to, serum-free subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis Clin Ther 36 1946-27
[10]
Fresco P(2017)Reasons for discontinuation of subcutaneous interferon beta-1a three times a week among patients with multiple sclerosis: a real-world cohort study BMC Neurol 17 57-100